---
title: WMT
date: 2021-09-06T09:31:07Z
modified: 2026-08-12T09:25:44Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/wmt/"
type: portfolio
status: publish
excerpt: ""
wpid: 91795
language:
  - English
post_translations:
  - pll_6135dfb6abe46
branchen22:
  - Oncology
sectors:
  - Pharmaceuticals
focus_areas:
  - Immunology
timestamp: 2026-08-12T09:25:44Z
tags:
  - English
  - pll_6135dfb6abe46
  - Oncology
  - Pharmaceuticals
  - Immunology
---

## Beschreibungstext

WMT developes small molecules for cancer indications by targeting the Warburg Metabolism. The Warburg Metabolism was first described 100 years ago by Otto Heinrich Warburg and the therapeutic approach is based on the fact that many cancer cells predominantly produce their energy through a high rate of glycolysis followed by lactic acid fermentation even in the presence of abundant oxygen. Using this mechanism for the treatment of cancer turns out to be very difficult, as interventions targeted at the sugar metabolism also cause harm to healthy cells. The approach WMT is using offers an improved therapeutic window as opposed to classical cancer medicines.

## Unternehmenswebsite

www.wm-therapeutics.com

## Adresse

WMT AG
Waldhofer Str. 104
69123 Heidelberg

## Kontakt

Array

Array